×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
THE STATE KEY LA... [2]
Faculty of Healt... [1]
Authors
HU YUANJIA [1]
Document Type
Journal article [2]
Date Issued
2022 [1]
2021 [1]
Language
英語English [2]
Source Publication
JAMA - Journal o... [1]
Journal of Ethno... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
A network pharmacology-based study on the quality control markers of antithrombotic herbs: Using Salvia miltiorrhiza - Ligusticum chuanxiong as an example
Journal article
Zhang, Dai Yan, Peng, Ruo Qian, Wang, Xu, Zuo, Hua Li, Lyu, Li Yang, Yang, Feng Qing, Hu, Yuan Jia. A network pharmacology-based study on the quality control markers of antithrombotic herbs: Using Salvia miltiorrhiza - Ligusticum chuanxiong as an example[J]. Journal of Ethnopharmacology, 2022, 292(115197).
Authors:
Zhang, Dai Yan
;
Peng, Ruo Qian
;
Wang, Xu
;
Zuo, Hua Li
;
Lyu, Li Yang
; et al.
Favorite
|
TC[WOS]:
19
TC[Scopus]:
21
IF:
4.8
/
4.8
|
Submit date:2022/05/13
Salvia Miltiorrhiza
Ligusticum Chuanxiong
Network Pharmacology
Bilayer Network
Quality Control Markers
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival among Patients with Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial
Journal article
Wang, Xi, Wang, Shu Sen, Huang, Heng, Cai, Li, Zhao, Li, Peng, Rou Jun, Lin, Ying, Tang, Jun, Zeng, Jian, Zhang, Le Hong, Ke, Yong Li, Wang, Xian Ming, Liu, Xin Mei, Chen, Qian Jun, Zhang, An Qin, Xu, Fei, Bi, Xi Wen, Huang, Jia Jia, Li, Ji Bin, Pang, Dan Mei, Xue, Cong, Shi, Yan Xia, He, Zhen Yu, Lin, Huan Xin, An, Xin, Xia, Wen, Cao, Ye, Guo, Ying, Su, Yan Hong, Hua, Xin, Wang, Xin Yue, Hong, Ruo Xi, Jiang, Kui Kui, Song, Chen Ge, Huang, Zhang Zan, Shi, Wei, Zhong, Yong Yi, Yuan, Zhong Yu. Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival among Patients with Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial[J]. JAMA - Journal of the American Medical Association, 2021, 325(1), 50-58.
Authors:
Wang, Xi
;
Wang, Shu Sen
;
Huang, Heng
;
Cai, Li
;
Zhao, Li
; et al.
Favorite
|
TC[WOS]:
248
TC[Scopus]:
149
IF:
63.1
/
66.8
|
Submit date:2021/12/07